{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:45:55Z","timestamp":1790077555987,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.thromres.2014.08.021","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T21:17:00Z","timestamp":1409347020000},"page":"980-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma"],"prefix":"10.1016","volume":"134","author":[{"given":"J.","family":"Gebhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Skrabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"M\u00fcld\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"N\u00f6sslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Vanura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Simonitsch-Klupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mitterbauer-Hohendanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.08.021_bb0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/asheducation.V2012.1.426.3798535","article-title":"The many faces of marginal zone lymphoma","volume":"2012","author":"Zinzani","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.thromres.2014.08.021_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3324\/haematol.11934","article-title":"Autoimmune thrombocytopenia in non-Hodgkin's lymphomas","volume":"93","author":"Hauswirth","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2014.08.021_bb0015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","article-title":"Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas","volume":"48","author":"Hauswirth","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.thromres.2014.08.021_bb0020","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3109\/10428194.2011.580474","article-title":"Acquired immune-mediated thrombophilia in lymphoproliferative disorders","volume":"52","author":"Lechner","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.thromres.2014.08.021_bb0025","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.021_bb0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC)","volume":"93","author":"Troussard","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.08.021_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thromres.2014.08.021_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.021_bb0045","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.thromres.2014.08.021_bb0050","doi-asserted-by":"crossref","first-page":"W435","DOI":"10.1093\/nar\/gkh412","article-title":"IMGT\/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis","volume":"32","author":"Giudicelli","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.thromres.2014.08.021_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1191\/096120398678919688","article-title":"Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis","volume":"7","author":"Wahl","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2014.08.021_bb0060","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/sj.bjc.6602504","article-title":"Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis","volume":"92","author":"Mohren","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.thromres.2014.08.021_bb0065","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.thromres.2012.03.019","article-title":"Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population","volume":"130","author":"Park","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.08.021_bb0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01788133","article-title":"Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection","volume":"67","author":"Jaeger","year":"1993","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2014.08.021_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/0961203302lu178oa","article-title":"Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome","volume":"11","author":"Erkan","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2014.08.021_bb0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejim.2004.03.005","article-title":"Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia","volume":"15","author":"Delgado Alves","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.thromres.2014.08.021_bb0085","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3324\/haematol.12682","article-title":"The postoperative splenic\/portal vein thrombosis after splenectomy and its prevention\u2013an unresolved issue","volume":"93","author":"Krauth","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2014.08.021_bb0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/SLA.0b013e318278d1bf","article-title":"Splenectomy for massive splenomegaly: long-term results and risks for mortality","volume":"258","author":"Taner","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.thromres.2014.08.021_bb0095","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.3748\/wjg.v19.i24.3854","article-title":"Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma","volume":"19","author":"Wu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.thromres.2014.08.021_bb0100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/bjh.12036","article-title":"Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma","volume":"159","author":"Else","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.08.021_bb0105","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":"Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2014.08.021_bb0110","first-page":"1811","article-title":"Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome","volume":"29","author":"Kalpadakis","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.thromres.2014.08.021_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2119\/2005-00001.Stamatopoulos","article-title":"Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma","volume":"10","author":"Stamatopoulos","year":"2004","journal-title":"Mol Med"},{"key":"10.1016\/j.thromres.2014.08.021_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients","volume":"3","author":"Thieblemont","year":"2002","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.thromres.2014.08.021_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.seminhematol.2010.01.004","article-title":"Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab","volume":"47","author":"Bennett","year":"2010","journal-title":"Semin Hematol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814004575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814004575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T22:15:54Z","timestamp":1598220954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814004575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0049384814004575"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.08.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}